Lupin Limited has informed the Exchange regarding a press release dated Jun 04, 2026, titled " Lupin Receives Approval from U.S. FDA for Ranluspec (ranibizumab) Injection".
Lupin Limited has informed the Exchange regarding a press release dated Jun 04, 2026, titled " Lupin Receives Approval from U.S. FDA for Ranluspec (ranibizumab) Injection".